-
Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis
Measuring the uptake of tamoxifen, and the alternative raloxifene, in national prescribing data sets
Categories
- OpenPrescribing
- Policy Insights
-
Trends, geographical variation and factors associated with prescribing of gluten-free foods in English primary care: a cross-sectional study
Gluten-free prescribing is in a state of flux, with substantial clinically unwarranted variation between practices and CCGs.
Categories
- OpenPrescribing
-
A cross-sectional study of all clinicians' conflict of interest disclosures to NHS hospital employers in England 2015-2016.
Documenting how NHS trusts in the UK record and share disclosures of conflict of interest by their employees
Categories
- Policy Insights
- Research Integrity
-
Variation in diagnostic test requests and outcomes: a preliminary metric for OpenPathology.net
Nature variation in diagnostic tests
Categories
- OpenPathology
-
Prevalence of clinical trial status discrepancies: A cross-sectional study of 10,492 trials registered on both ClinicalTrials.gov and the European Union Clinical Trials Register.
Identifying errors and omissions in registries, including discrepancies between descriptions of the same trial in different registries.
Categories
- TrialsTracker
-
OpenPrescribing: normalised data and software tool to research trends in English NHS primary care prescribing 1998–2016
Publicly available data can be made accessible through interactive online tools to help researchers and policy-makers explore time trends in prescribing.
Categories
- OpenPrescribing
-
New mechanism to identify cost savings in English NHS prescribing: minimising 'price per unit', a cross-sectional study
We have developed a new method to identify and enable large potential cost savings within NHS community prescribing. Given the current pressures on the NHS, it is vital that these potential savings are realised.
Categories
- OpenPrescribing
-
Pharmaceutical companies' policies on access to trial data, results, and methods: audit study.
Identifying the policies of major pharmaceutical companies on transparency of trials,
Categories
- Research Integrity
-
The WHO joint statement from funders on trials transparency
Commenting on the WHO's joint statement on clinical trials transparency
Categories
- Research Integrity
-
The TrialsTracker: Automated ongoing monitoring of failure to share clinical trial results by all major companies and research institutions.
Developing an online resource that automatically identifies the sponsors with the best and worst record for failing to share trial results
Categories
- TrialsTracker
-
OpenTrials: towards a collaborative open database of all available information on all clinical trials
Describing OpenTrials - a collaborative and open database for all available structured data and documents on clinical trials.
Categories
- TrialsTracker
-
Make journals report clinical trials properly
Describing the need for better reporting of clinical trials.
Categories
- Policy Insights
- TrialsTracker
-
Fixing flaws in science must be professionalized
Discussing the need for greater transparency around data and analytics.
Categories
- Policy Insights
- Research Integrity
-
Antivirals, pandemic planning, and failure to heed calls for trial data
Editorial
Categories
- Policy Insights
- TrialsTracker
-
How medicine is broken, and how we can fix it
Editorial
Categories
- Policy Insights
- Research Integrity
-
How to get all trials reported: audit, better data, and individual accountability
Discussing the rationale for WHO's new position calling for prompt reporting and public disclosure of interventional clinical trial results
Categories
- Policy Insights
- TrialsTracker
